Lilly Zyprexa Strategies Include Medicaid Disease Management
Executive Summary
Lilly is using a schizophrenia disease management program in Colorado as a pilot program to demonstrate that careful patient management can save states more money than supplemental rebates
You may also be interested in...
Texas Medicaid Restricts Zyprexa Use; Effect To Stabilize Soon, Lilly Says
The impact of Texas Medicaid's decision to require prior authorization for Zyprexa will stabilize after about six months, Lilly Investor Relations Manager Heidi Straub said April 19
Texas Medicaid Restricts Zyprexa Use; Effect To Stabilize Soon, Lilly Says
The impact of Texas Medicaid's decision to require prior authorization for Zyprexa will stabilize after about six months, Lilly Investor Relations Manager Heidi Straub said April 19
Zyprexa Under Medicare: Shift From Medicaid Means $200 Mil. Less Rebates
The transfer of "dual eligible" Zyprexa patients from Medicaid to the new Medicare drug benefit means that Lilly's rebate payments to states will be reduced by about $200 mil. per year
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: